From cfDNA Methylation to Molecular Subtyping: Unlocking New Signals from Liquid Biopsies
Thursday, January 28, 2027 at 11:30 AM to 12:00 PM · 30 min. (Europe/London)
Main Stage
Day 2 - Thursday 28th January
DiagnosticsLiquid BiopsySequencing
Information
- Beyond mutations: How cfDNA methylation patterns can reveal tumour biology and complement traditional genomic biomarkers.
- Molecular subtyping from blood: Using methylation signatures to classify patients into biologically meaningful subtypes and improve disease characterisation.
- From signal to clinical value: Challenges in translating cfDNA methylation-based subtyping into robust, scalable tools for early detection, diagnosis and patient stratification.
